HEEYOUNG KIM: Open Payments
NPI 1629692637 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 13 payments from 8 companies in 2025. Trend: 2023 $1,697 · 2024 $644 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $101 |
| SANOFI-AVENTIS U.S. LLC | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Corcept Therapeutics | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: Veozah, XIFAXAN, TZIELD, SPRAVATO, INSPIRE, Korlym, Rybelsus, Kerendia.
Industry payments across GA — which companies pay providers there.
